Ge Healthcare

This study is testing a new contrast agent called mangaciclanol for MRI scans. It aims to help doctors see and diagnose suspicious areas (lesions) in the brain or body more clearly than with the current standard agent. The trial will enroll 640 adults who are already scheduled fo…

This study is testing a new type of PET/CT scan to see if it can better detect cancer that has spread to the lining of the abdomen (peritoneal carcinomatosis) in patients with certain cancers. About 175 adults with colorectal, gastric, ovarian, or pancreatic cancer who are suspec…

This study is testing a new mobile device that monitors patients' vital signs in the hospital. Up to 50 adult patients will wear the monitor for up to 3 days. The main goal is to collect feedback from both the patients and their nurses/doctors about how well the device works and …

This study aims to gather feedback from doctors and nurses on a new sensor and cable used to monitor muscle relaxation during surgery. The device gives electrical pulses to a nerve in the wrist and measures the muscle's response. Researchers want to know how easy the device is to…